Biovac Secures Deal to Produce Pneumonia Vaccine

Biovac secures a deal with Biological E to produce a pneumonia vaccine in Africa, promoting vaccine independence continent-wide.

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Tagged Africa, Africa CDC, Biological E, Biovac, Cape Town, Gavi, PCV14, Pneumonia, Public Health, South Africa, Technology Transfer, Vaccine Independence, Vaccine Manufacturing